118 related articles for article (PubMed ID: 25406994)
1. Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patients.
Danza K; De Summa S; Pilato B; Carella M; Palumbo O; Popescu O; Paradiso A; Pinto R; Tommasi S
J Transl Med; 2014 Nov; 12():319. PubMed ID: 25406994
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression profiling in male and female familial breast cancer.
Pinto R; De Summa S; Danza K; Popescu O; Paradiso A; Micale L; Merla G; Palumbo O; Carella M; Tommasi S
Br J Cancer; 2014 Dec; 111(12):2361-8. PubMed ID: 25393370
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer.
Melchor L; Honrado E; Huang J; Alvarez S; Naylor TL; García MJ; Osorio A; Blesa D; Stratton MR; Weber BL; Cigudosa JC; Rahman N; Nathanson KL; Benítez J
Clin Cancer Res; 2007 Dec; 13(24):7305-13. PubMed ID: 18094411
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA signatures in hereditary breast cancer.
Murria Estal R; Palanca Suela S; de Juan Jiménez I; Egoavil Rojas C; García-Casado Z; Juan Fita MJ; Sánchez Heras AB; Segura Huerta A; Chirivella González I; Sánchez-Izquierdo D; Llop García M; Barragán González E; Bolufer Gilabert P
Breast Cancer Res Treat; 2013 Nov; 142(1):19-30. PubMed ID: 24129975
[TBL] [Abstract][Full Text] [Related]
5. TGFbeta and miRNA regulation in familial and sporadic breast cancer.
Danza K; De Summa S; Pinto R; Pilato B; Palumbo O; Carella M; Popescu O; Digennaro M; Lacalamita R; Tommasi S
Oncotarget; 2017 Aug; 8(31):50715-50723. PubMed ID: 28881597
[TBL] [Abstract][Full Text] [Related]
6. Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis.
Yin Y; Shen C; Xie P; Cheng Z; Zhu Q
Breast; 2016 Apr; 26():1-10. PubMed ID: 27017236
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG
Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863
[TBL] [Abstract][Full Text] [Related]
8. MiR-578 and miR-573 as potential players in BRCA-related breast cancer angiogenesis.
Danza K; De Summa S; Pinto R; Pilato B; Palumbo O; Merla G; Simone G; Tommasi S
Oncotarget; 2015 Jan; 6(1):471-83. PubMed ID: 25333258
[TBL] [Abstract][Full Text] [Related]
9. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 protein expression and its correlation with ER/PR status in sporadic and familial breast cancer in Eastern Indian patients--a hospital based study.
Ashraf M; Jha JK; Mukherjee N; Panda CK; Nayak S; Jadhav TS; Dikshit N; Nath NC; Chakraborty J; Biswas J
J Indian Med Assoc; 2011 Dec; 109(12):873-8. PubMed ID: 23469566
[TBL] [Abstract][Full Text] [Related]
11. p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations.
Sensi E; Tancredi M; Aretini P; Cipollini G; Naccarato AG; Viacava P; Bevilacqua G; Caligo MA
Breast Cancer Res Treat; 2003 Nov; 82(1):1-9. PubMed ID: 14672397
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer.
Dugo M; Huang X; Iorio MV; Cataldo A; Tagliabue E; Daidone MG; Wu J; Orlandi R
Breast; 2018 Jun; 39():46-52. PubMed ID: 29597130
[TBL] [Abstract][Full Text] [Related]
13. Differences in the progesterone receptor contents between familial breast cancers and sporadic breast cancers stratified by patient age.
Fukutomi T; Akashi-Tanaka S
Surg Today; 2001; 31(11):963-7. PubMed ID: 11766082
[TBL] [Abstract][Full Text] [Related]
14. Different methylation and microRNA expression pattern in male and female familial breast cancer.
Pinto R; Pilato B; Ottini L; Lambo R; Simone G; Paradiso A; Tommasi S
J Cell Physiol; 2013 Jun; 228(6):1264-9. PubMed ID: 23160909
[TBL] [Abstract][Full Text] [Related]
15. Inferring coregulation of transcription factors and microRNAs in breast cancer.
Wu JH; Sun YJ; Hsieh PH; Shieh GS
Gene; 2013 Apr; 518(1):139-44. PubMed ID: 23246694
[TBL] [Abstract][Full Text] [Related]
16. Familial and sporadic breast cancers: differences in clinical, histopathological, and immunohistochemical features.
D'Eredita' G; Giardina C; Napoli A; Troilo VL; Fischetti F; Berardi T
Int J Surg Pathol; 2011 Dec; 19(6):724-32. PubMed ID: 20308044
[TBL] [Abstract][Full Text] [Related]
17. Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers.
Yan M; Shield-Artin K; Byrne D; Deb S; Waddell N; ; Haviv I; Fox SB
BMC Cancer; 2015 Jul; 15():506. PubMed ID: 26152113
[TBL] [Abstract][Full Text] [Related]
18. Copy number profiling by array comparative genomic hybridization identifies frequently occurring BRCA2-like male breast cancer.
Biesma HD; Schouten PC; Lacle MM; Sanders J; Brugman W; Kerkhoven R; Mandjes I; van der Groep P; van Diest PJ; Linn SC
Genes Chromosomes Cancer; 2015 Dec; 54(12):734-44. PubMed ID: 26355282
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological and clinicopathological characteristics of BRCA-positive and BRCA-negative breast cancer patients in Greece.
Triantafyllidou O; Vlachos IS; Apostolou P; Konstantopoulou I; Grivas A; Panopoulos C; Dimitrakakis C; Kassanos D; Loghis C; Bramis I; Vlahos N; Yannoukakos D; Fostira F
J BUON; 2015; 20(4):978-84. PubMed ID: 26416046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
